Wessex Private GP is trialling a new service to improve the care we deliver. Using this service, and only with your permission, our GPs can access to your NHS record. For those who opt in, your your GP will be able to view things like your medication list, hospital letters and even test results.

If you book an appointment, we will automatically send an email asking permission for us to use this service. We will send this automatically only once, however your GP can resend it at any time should they need to. Thus, if you opt out but change your mind later, that’s fine. So, if you would like us to be able to access your NHS record, please simply select the link in the email and follow the instructions. If you think you should have received an email about this, but haven’t, please let us know.

Why record access matters

We care about your data, and we know that sharing your personal information feel daunting. However, we also care about your health, and we know that if doctors can’t access important information, things are worse for patients. As this article starkly points out,  in 2024, ‘Coroners in England and Wales have issued 36 warnings… over inadequate sharing of NHS patient information, with some patients dying because clinicians couldn’t access important details about their needs.’

At the end of the day, what you do with your personal information is up to you. However, we know that better access to your records can save you and your doctor time, and will help us deliver better care. If you have any questions about this process, please ask us. We are always happy to discuss your concerns.

Prostate cancer sits behind lung cancer as the second leading cause of cancer death for men, affects one in seven men, and kills as many men as breast cancer kills women. Like bowel and breast cancer, its progression is linear. Catch it early, and your chance of surviving is greater than 95%.

Why are more men presenting with stage 4, the very worst form of prostate cancer? Because the disease is not found early enough.

PSA, or prostate-specific antigen, is a protein produced in the prostate gland that helps liquefy semen. A certain amount leaks into the circulation and can be detected with a blood test. That amount can increase if the gland enlarges, as it does when we age, or if the architecture of the gland is disrupted, as in cancer.

What does your PSA reading mean?

A PSA reading on its own is of limited value, but sequential readings every year can be used to calculate the velocity of change, a useful warning sign. Moreover, if we know the size of the prostate, measured with an ultrasound or MRI scan, we can calculate the PSA density, which can again enable us to calculate risk. For example, a PSA of 8 in an 80 ml prostate gland is normal, and a PSA of 3 in a 30 ml prostate gland is normal. However, a PSA of 8 in a 30 ml prostate is definitely abnormal.

A high PSA, high PSA density, or PSA velocity may raise concern. If PSA is a concern then an MRI scan, costing about £650, can identify abnormal areas of the prostate or provide reassurance. In addition, a blood test called a Stockholm 3 test, costing £350, is a polygenic risk marker that can again predict your risk.

A biopsy may then be advised. We have moved on from the prostate biopsy done through the rectum, which was associated with a high risk of complications, especially infection, to a transperineal biopsy through the skin between the anus and the scrotum, which is safer, less unpleasant, and targeted at any abnormal areas noticed on the MRI scan.

What if the biopsy confirms prostate cancer?

Cancers are graded according to their severity and their stage of spread. Not all cancers need treating, and for those that do, the modern treatments are much more effective at minimising side effects.

The decision not to instigate a national screening program for prostate cancer, in my opinion, is a travesty and is based on outdated assumptions and without consideration of the advances, effectiveness, and risk reductions with screening and treatments. I don’t know a male doctor who doesn’t have his PSA done regularly. I recommend starting by age 50 at the latest.

A PSA checkup with Wessex Private GP costs £185 and can be booked with the following link. I truly think it’s worth having the discussion. Why wouldn’t you?

WPGP – we’re here for you.

 


About the author

Dr Charles Middle

Dr Charles Middle is a highly experienced GP and founder of Wessex Private GP. His special interests include orthopaedic medicine, minor surgery, mental health and adolescent medicine, and he holds a Diploma in Sports Medicine.

This post has been written or personally reviewed by Dr Middle.

Read Dr Middle’s full biography →

Medicals have advanced since we were in school or may have joined the forces. They’re not to be feared but embraced as an opportunity to work upstream on your health and to prevent or catch issues before they become problematic. Moreover, they are a chance to set a baseline for future comparison and monitoring (for example, PSA testing) and to begin a healthcare relationship with a trusted GP.

There are many medical offerings on the market which are excellent and a good start, but none that can be as bespoke as a discussion with an experienced doctor about you, your lifestyle, your health experiences and expectations, who will then perform appropriate tests and interpret results for you as an individual. Cholesterol testing and the need to take statins are a very good example of such a dilemma that may require a nuanced medical discussion.

One size does not fit all

If you’re not sure what medical you need or how to start this process, just book in and start the conversation. A standard appointment or extended appointment to talk this through will be the basis of either a one-off or, preferably, an ongoing relationship. You do not need to necessarily book for a bespoke medical or a standard male or female medical.

For example, for the menopause, we don’t offer a specific menopause medical because that could be too prescriptive. As the menopause is a varied and complicated medical and lifestyle condition, and conversation and testing can go in various different directions, an appointment with a GP of your choosing to discuss this issue is the place to start. We all have huge experience in this area.

Sure, if you are competing in a sports event or motorsports event, charity skydiving, or need a form signed for travel or that bucket-list bungee jump in Bolivia, we can advise and oblige. Then there are occupational and visa medicals  – we can do some, but not all. Just ask, and we will reply promptly.

WPGP – we’re here for you.

Recent media reports have raised understandable concerns about the safety of GLP-1 medicines such as Mounjaro (tirzepatide) and Wegovy/Ozempic (semaglutide), with headlines suggesting that hundreds of deaths have been linked to these treatments.

The figures can sound alarming. However, it is important to understand what these reports actually mean – and what they do not mean.

What are the reported numbers?

The latest figures come from the UK Medicines and Healthcare products Regulatory Agency (MHRA) Yellow Card reporting system. This system collects reports of suspected adverse drug reactions from patients, members of the public and healthcare professionals.

Up to 7 July 2026, tirzepatide had been associated with 100,810 reported adverse reactions through the Yellow Card scheme, including 10,434 classified as serious and 98 with a fatal outcome. The total number of reports classified as having a fatal outcome was 120.

For semaglutide, there were 44,073 reported adverse reactions, including 4,892 classified as serious and 37 with a fatal outcome. The total number of reports classified as having a fatal outcome was 59.

These numbers should not be interpreted as meaning that these medicines caused 120 or 59 deaths.

A Yellow Card report does not prove that the medicine caused the event

This is probably the most important point.

A Yellow Card report means that someone has suspected that a medicine may have contributed to an adverse event. It does not establish that the medicine caused it.

As the MHRA explains:

“Reports of a suspected adverse reaction do not necessarily mean that the medicine caused the event.”

A person taking a GLP-1 medicine may unfortunately become seriously ill or die for many different reasons. They may already have conditions such as obesity, diabetes, high blood pressure, cardiovascular disease or kidney disease, all of which can increase the risk of serious illness.

Professor Naveed Sattar, professor of cardiometabolic medicine at the University of Glasgow, highlighted this important issue:

“The people prescribed these medicines often already have conditions such as obesity, diabetes, high blood pressure, heart disease, and kidney disease. These conditions themselves increase the risk of serious illness and premature death.

“As a result, when millions of individuals at higher risk take a medicine, some will inevitably experience major health events or die when on treatment, regardless of whether the medicine played any role.”

In other words, a death occurring while someone is taking a medicine is not necessarily a death caused by that medicine.

Why are there so many reports?

There are now millions of people using GLP-1 medicines in the UK.

The more widely a medicine is prescribed, the more adverse events will inevitably occur among people taking it—even when those events are unrelated to the medicine.

There is also an important limitation of spontaneous reporting systems such as Yellow Card: a single person can submit multiple reports, so the number of reports does not equal the number of individual patients.

Reporting can also increase when public awareness of a potential side effect increases.

The MHRA therefore emphasises:

“We want to reassure patients that GLP-1 medicines are safe for the majority of users. It is important to place these reports in the context of the millions of GLP-1 prescriptions issued in the UK. Reporting volumes can be influenced by increased use, greater awareness of a potential adverse reaction, and other factors.”

Does this mean there are no serious risks?

No. GLP-1 medicines are not risk-free, and it is important to take potential adverse effects seriously. Gastrointestinal symptoms are among the most frequently reported side effects, including nausea, vomiting, diarrhoea,

The bottom line

GLP-1 medicines are powerful medicines, not risk-free medicines, and reports of serious adverse events—including pancreatitis—should always be taken seriously. They also need to be prescribed thoughtfully, with appropriate assessment, monitoring and clear advice about warning symptoms.

However, the recent headlines can give a misleading impression of the evidence. A Yellow Card report is a report of a suspected reaction, not proof that the medicine caused the event, and the numbers cannot be used to calculate an individual’s risk of dying from treatment.

For most people who are appropriately assessed and prescribed a GLP-1 medicine, the available evidence remains reassuring. Large randomised clinical trials have not shown an increased overall risk of death, and GLP-1 medicines have demonstrated important benefits for many people living with obesity, diabetes and cardiovascular risk.

The MHRA’s current position is clear:

“On the basis of the current evidence, the benefits of GLP-1 receptor agonists outweigh the potential risks when used in line with their authorised uses.”

The sensible approach is therefore neither to dismiss the risks nor to be frightened by alarming headlines. Good prescribing means carefully weighing the potential benefits and risks for each individual, using the best available evidence. These medicines should be used as part of a carefully considered, individualised treatment plan, with patients understanding both the potential benefits and risks and knowing when to seek medical advice.

Good prescribing is about weighing the risks and benefits for the individual – not simply asking whether a medicine has risks, but whether its potential benefits outweigh those risks for that particular person.

Sources and further reading

  1. Wise J. GLP-1 deaths: Are weight loss drugs linked to hundreds of fatalities? BMJ. 2026;394:e100557. doi:10.1136/bmj-2026-100557. Published 12 August 2026.
  2. Koronka P. More than 100 deaths after Mounjaro or Wegovy use reported. The Times. 5 August 2026.
  3. Whittaker R. More than 150 deaths reported after weight loss drug use. The Independent. 6 August 2026.
  4. Sky News. Hundreds of deaths suspected of being linked to weight-loss jabs reported to regulator. 6 August 2026.

 


About the author

Dr Ulrike Naumann

Dr Ulrike Naumann runs our Weight Loss Clinic and is committed to providing holistic, individualised care to help you develop healthier habits, including an improved relationship with food and exercise. She has over three decades of experience in General Practice with a special interest in obesity.

This post has been written or personally reviewed by Dr Naumann.

Read Dr Naumann’s full biography →

You may have come across the term ‘microdosing‘ on social media or in online support groups.

Microdosing refers to taking smaller doses of a GLP-1 medicine (such as Mounjaro® or Wegovy®) than those recommended in the licensed prescribing schedule, increasing the dose more slowly than usual, or taking the medication less frequently than prescribed.

Some people choose this approach in the hope of reducing side effects, lowering treatment costs or maintaining weight loss on the smallest effective dose.

Is microdosing evidence-based?

At present, there is very limited scientific evidence to support microdosing as a routine treatment strategy.

The impressive weight loss and health benefits reported in large clinical trials of Mounjaro® (tirzepatide) and Wegovy® (semaglutide) were achieved using the licensed dose-escalation schedules. These schedules have been carefully studied to optimise effectiveness while allowing the body to adapt gradually to treatment.

Although some people report excellent results with lower doses, these experiences are largely anecdotal. We do not yet have robust research to tell us:

  • how effective microdosing is in the long term
  • whether weight loss is maintained as successfully
  • whether lower doses provide the same improvements in diabetes, blood pressure, cholesterol and cardiovascular risk
  • which patients are most likely to benefit.

Further research is needed before microdosing can be recommended routinely.

Why isn’t everyone prescribed the highest dose?

Contrary to popular belief, the aim of treatment is not to reach the maximum dose.

Instead, the goal is to find the lowest effective dose that:

  • provides good appetite control
  • supports steady, sustainable weight loss
  • is well tolerated
  • allows you to enjoy a nutritious diet
  • helps preserve muscle mass through adequate protein intake and physical activity
  • fits comfortably into your lifestyle.

Higher doses are not always better. Some people achieve excellent results on lower doses and do not need to increase further.

When might remaining on a lower dose be appropriate?

Your clinician may recommend staying on your current dose for longer if you are:

  • continuing to lose weight steadily
  • feeling satisfied with your appetite control
  • experiencing minimal side effects
  • making sustainable lifestyle changes
  • progressing towards your agreed health goals.

Treatment should always be individualised rather than following a ‘one size fits all’ approach.

Are there any disadvantages?

Remaining on a very low dose may mean:

  • slower weight loss
  • less appetite suppression over time
  • smaller improvements in obesity-related health conditions
  • uncertainty because long-term outcomes have not yet been well studied.

For some people, increasing to the next licensed dose may provide additional benefits.

What do current prescribing guidelines recommend?

Current UK and international prescribing guidance is based on the licensed dosing schedules used in large clinical trials.

These guidelines recommend gradual dose escalation unless there is a clinical reason to pause dose increases, such as significant side effects or other individual circumstances.

For this reason, healthcare professionals generally prescribe within the licensed dosing recommendations while tailoring treatment to each person’s needs.

Our approach at Wessex Private GP

We recognise that every patient’s weight-loss journey is unique.

Rather than automatically increasing your medication every four weeks, we review your progress carefully at each appointment and make shared decisions based on:

  • your weight-loss progress
  • changes in waist circumference and body composition where appropriate
  • hunger and food cravings
  • side effects
  • nutritional intake
  • physical activity and muscle preservation
  • your confidence in maintaining healthy habits
  • your personal goals and preferences.

Medication is only one part of successful long-term weight management. Developing sustainable eating habits, maintaining regular physical activity, prioritising sleep, managing stress and preserving muscle mass remain essential for achieving lasting health improvements.

Key message

The best dose is not necessarily the highest dose – it is the lowest dose that safely and effectively supports your health goals.

Your treatment plan will be reviewed regularly and adjusted using shared decision-making, taking into account both the available scientific evidence and your individual response to treatment. Please do not alter the dose or frequency of your medication without discussing it with your prescribing clinician.


About the author

Dr Ulrike Naumann

Dr Ulrike Naumann runs our Weight Loss Clinic and is committed to providing holistic, individualised care to help you develop healthier habits, including an improved relationship with food and exercise. She has over three decades of experience in General Practice with a special interest in obesity.

This post has been written or personally reviewed by Dr Naumann.

Read Dr Naumann’s full biography →

Here we go again. Reports of sickness and death in far-away places. An illness behaving in troublesome ways. Memories of a time so near that it hardly needs recalling, but so far in its experience from the life we know, that it seems like a dream.

Is Hanta the next COVID? The short answer is… ‘probably not’… the (slightly) longer answer is, ‘only time will tell for sure…’

Not very reassuring, I suppose, but in a world in which we constantly and deftly manage unclear and ever-evolving risk, it isn’t really that different from the daily commute.

What is Hantavirus?

The Hantaviruses are a family of disease-causing nasties defined by their structure (they are enveloped viruses with a negative‑sense, single‑stranded RNA genome, for those who care to know). A defining characteristic is their predilection for infecting certain animals, especially rodents, which carry them without becoming unwell.

Humans are typically infected by breathing it in from contaminated rodent urine, faeces, or saliva. In contrast to many related viruses, hantaviruses are not spread by insects. There is only one strain of hantavirus where an infected human can pass it on to another, the strain currently under scrutiny, the ‘Andes’ strain.

How do pandemics happen?

Human to human transmission of an illness is not necessary for it to cause misery. Indeed malaria, which must be in the top 5 most appalling illnesses by almost any measure, can only be spread by blood. In the overwhelming majority of cases, this is through mosquito bites, other means of transmission such as via blood transfusion have been documented very rarely.

All this to say, you aren’t going to catch Malaria by sitting next to someone on the bus who has it, no matter how cough-y or mask-free that person is. Human to human transmission is necessary for a disease to become a pandemic. Moreover, that transmission has to be quite likely. The practical measure of this likelihood is the ‘R value’ of an illness (remember that?). The R value is the number of people an infected person is expected to pass the disease on to under present conditions. If R is more than 1, we all have a bad time as the number of infected people grows. If it is less than 1, the illness peters out.

Why are we concerned now?

I think, by and large, we are concerned now because of what happened with COVID. We (and by we, I mean largely the non-medical media) see the similarities but not the differences and know that, given the huge impact COVID had on our collective consciousness, stories about a potentially similar situation will sell newspapers and drive clicks. SARS-CoV-2 was a virus, unknown to the general public, with a history of confirmed human-to-human transmission, that causes illness and death. The Andes strain of hantavirus is a virus, unknown to the general public, with a history of confirmed human-to-human transmission, that causes illness and death.

However, here the similarities stop. Whereas SARS-CoV-2 was an entirely new thing, the Andes strain is not, and current evidence suggests that this virus is not behaving significantly differently than it has before.

What happened in the past?

Previous outbreaks have demonstrated transmission between people, some of whom have died. This sounds ominous, but it is actually quite reassuring. We have seen all this before, including deaths, without a pandemic. The Andes strain of hantavirus simply wasn’t that transmissible in the past; outbreaks happened, but they were relatively easily contained.

 

Hantavirus Case Study:

In 2018–19 in and around Epuyén, Argentina, the Andes hantavirus caused 34 (confirmed) infections and 11 deaths. According to a 2020 study, transmission was mostly driven by three people who went to crowded social events while symptomatic. The outbreak was halted through isolation, quarantine, and contact tracing, reducing the reproduction number below 1.

Could things be different this time?

Yes, they could. We shouldn’t be complacent by any means. Viruses can evolve over time, and past behaviour is not a guarantee of future patterns. This is why there is some dissonance between the messaging coming from trusted organisations like the WHO, which are trying to project an image of calm confidence, and the attire of medical workers on the ground. People dressed up in full hazmat suits don’t visibly signal a virus that is difficult to catch.

Nevertheless, according to all the evidence we have now, the virus really is difficult to catch, but how stupid we would look, how hindsight would shame us, if it turned out that this virus had changed and we hadn’t taken sensible precautions. This, especially after the lessons our leaders are supposed to have learned during COVID. Hazmat suits are inconvenient. A pandemic is devastating.

So what should I do?

Nothing different. Avoid searching for daily updates on this; it doesn’t warrant it at present and will only cause unnecessary worry. Significant news will filter through, and should be sought from trusted sources like the WHO or WPGP (of course). If you have any concerns, we are here for you as always.

Dr Jonathan Tham Private GP

Dr Jonathan Tham

Dr Jonathan Tham

 

 

 

 

 

The information in this article was correct to the best of our knowledge at the time of publication.

Medications such as Mounjaro (tirzepatide) have changed the landscape of obesity and metabolic health treatment. By acting on appetite and blood sugar regulation pathways, the medication helps many people feel full sooner, experience fewer cravings, and reduce what patients often describe as “food noise.”

However, a reduced appetite can sometimes create a new challenge: people simply eat less overall, unintentionally reducing the nutrients their bodies need. For this reason, when taking Mounjaro, the focus should shift from simply eating less to eating well and eating strategically.

Protein becomes especially important

One of the most common dietary pitfalls is not eating enough protein. When appetite falls, people often gravitate towards small portions of carbohydrates such as toast, crackers, or cereal, because these feel easier to eat.

The problem is that low protein intake during weight loss can lead to muscle loss, fatigue, and a slower metabolism. Protecting muscle is particularly important as we age.

A helpful rule is to aim for around 25–40 grams of protein per meal. Good options include chicken, fish, eggs, Greek yoghurt, cottage cheese, lentils, chickpeas, or tofu. Building meals around protein first helps maintain strength, satiety, and metabolic health.

Skipping meals is usually not helpful

Because Mounjaro reduces appetite, some people end up eating only once or twice per day. While this may seem logical, it can result in low energy levels and inadequate nutrition.

Most people feel better with three smaller meals per day, sometimes with a small protein snack if needed. The goal is not large portions but balanced, nutrient-dense meals.

Fibre supports digestion and gut health

Another common issue when food intake drops is that fibre intake falls as well. Fibre plays an important role in gut health and can help prevent constipation, which some people notice when taking GLP-1 medications.

A good target is around 30 grams of fibre daily. Whole foods make this easier to achieve, particularly oats or oat bran, vegetables, beans, lentils, berries, and seeds such as chia or flax.

Be mindful of very fatty meals

Large, rich meals that are high in fat can sometimes worsen nausea or digestive discomfort while taking Mounjaro. Most people tolerate meals better when they are moderate in fat and balanced with protein and fibre.

For example, grilled fish with vegetables and quinoa is usually easier to tolerate than a heavy fried meal.

Don’t forget about hydration

Reduced appetite can also lead to drinking less fluid without realising it. Adequate hydration is important for digestion, energy, and overall wellbeing.

Most people benefit from aiming for around 1.5 to 2 litres of fluid daily, mainly from water, herbal teas, or sparkling water.

Supporting gut health

Because medications like Mounjaro slightly slow stomach emptying, supporting the gut microbiome can be helpful. Including small amounts of fermented foods each day may support digestive health.

Examples include kefir, live yoghurt, sauerkraut, or kimchi. These foods provide beneficial bacteria that can help maintain a healthy gut environment.

Eating more slowly can make a big difference

Another practical tip is simply to eat more slowly. Mounjaro strengthens the body’s natural fullness signals. When meals are eaten quickly, it’s easy to overshoot these signals and feel uncomfortably full afterwards.

Taking time with meals and stopping when comfortably satisfied rather than completely full usually improves comfort.

Whole foods still matter

While medication can reduce appetite, it cannot replace the benefits of nutrient-dense foods. Diets built around whole foods tend to provide more fibre, protein, vitamins, and minerals than ultra-processed alternatives.

A useful approach is to build meals around a simple structure:

protein + vegetables + whole grains

Examples might include grilled chicken with vegetables and quinoa, salmon with brown rice and greens, or a lentil and vegetable stew.

Protecting muscle during weight loss

Weight loss can involve both fat and muscle. Maintaining muscle mass becomes increasingly important with age, as muscle supports mobility, strength, and metabolic health.

Two habits help most:

  • adequate protein intake
  • regular resistance or strength activity

Even simple activities such as body-weight exercises, resistance bands, or light weights can make a difference.

A simple rule to remember

Many people find it helpful to keep one simple principle in mind:

‘Protein and fibre at every meal.’

For example:

  • Greek yoghurt with oat bran and berries for breakfast
  • Chicken salad with lentils and vegetables for lunch
  • Fish with vegetables and whole grains for dinner
  • Kefir or cottage cheese as a snack

This combination supports satiety, gut health, blood sugar stability, and muscle preservation.

Micronutrient supplementation

Sme people may not consistently obtain optimal levels of certain micronutrients from diet alone. For this reason, a simple daily supplement strategy is suggested. A general multivitamin containing B vitamins may support energy metabolism, while vitamin D is routinely recommended, particularly in older adults, to support bone and immune health.

Calcium intake is important for maintaining bone strength, especially in later life, and may be supplemented if dietary intake from dairy or fortified foods is low.

Iron supplementation may be particularly relevant if dietary intake is limited, for menstruating females, for patients with malabsorption syndromes or if blood tests indicate deficiency. It is sensible to discuss this with your clinician, particularly if you take other medications or have underlying health conditions.

The bigger picture

Medications such as Mounjaro are powerful tools for improving metabolic health and supporting weight loss. But they work best when combined with mindful nutrition and sustainable, healthy dietary habits.

Rather than focusing solely on eating less, the goal is to eat better — prioritising protein, fibre, whole foods, and balanced meals that nourish the body as weight changes.

Developing these habits early helps people maintain weight loss, avoid yo-yo dieting, and reduce the risk of weight regain—even if the medication is reduced or eventually stopped.

Many will feel anxious after hearing of the recent meningitis cases in Kent. There has been a serious outbreak linked to the Canterbury area, and the UK Health Security Agency (UKHSA) is leading the public health response, including arranging antibiotics and targeted vaccination for people thought to be at higher risk.¹

At the same time, it helps to keep the wider picture in mind. Meningococcal disease is still relatively uncommon overall: there were 378 confirmed cases in England in 2024/25, and the overall rate remains below 1 case per 100,000 people. In England, there has been a marked overall decline in confirmed invasive meningococcal disease cases over the last 2 decades from a peak of 2,595 cases in the epidemiological year 1999/2000.² This is reassuring, but it is not a reason to ignore symptoms, because meningitis can become serious very quickly.

But what is Meningitis B?

Meningitis means inflammation, or swelling, of the lining around the brain and spinal cord. It can be caused by viruses or bacteria.

Meningitis B, often shortened to MenB, is caused by a type of bacteria called meningococcal group B.⁴ This bacteria can cause meningitis and can also cause septicaemia, sometimes called blood poisoning, which means a serious infection in the bloodstream. If it does this, it is known as ‘Invasive Meningococcal Disease’ or ‘IMD’.

In England, MenB is the most common cause of IMD, causing 313 of 378 confirmed cases in 2024/25.² MenB spreads through close contact with saliva or droplets from the nose and mouth, for example through coughing, sneezing, kissing, or sharing drinks, utensils or vapes.

What do I need to know?

Symptoms can include a sudden fever, a severe or worsening headache, vomiting, a stiff neck, unusual sleepiness, confusion, cold hands and feet, discomfort in bright light, and a rash that does not fade when pressed with a glass. However, this last thing, the rash, is a late symptom, so if you notice the others, don’t wait around for the rash. Early symptoms can look like flu, a bad cold, or even a hangover, especially in teenagers and young adults.

So if someone is getting worse quickly, is difficult to wake, has a non-fading rash, has a seizure, or you are seriously worried, go to A&E or call 999 immediately. Acting early can be lifesaving.

What about the MenB vaccine?

The MenB vaccine used in the UK is called Bexsero.³ It was added to the routine NHS childhood vaccination schedule in September 2015, so babies born since then are likely to have been offered it.

This means that many older children, teenagers and adults will not have had it routinely on the NHS, unless they had it privately or are in a recognised higher-risk group. Children who missed their MenB vaccines can still have them on the NHS up to the age of 2. There are also special circumstances where MenB vaccine may be offered on the NHS outside the routine programme.⁶

This includes some people with medical conditions that increase the risk of severe infection, such as people without a working spleen, or people with problems in part of the immune system called the complement system, which is one of the body’s infection-fighting defences. It may also be offered as part of the public health response after certain exposures or outbreaks.

For this reason, we would encourage only those who clearly fall into one of these NHS groups to contact their NHS GP, although they may well contact you directly.⁶ Otherwise, if UKHSA or the NHS believes you may have been exposed without knowing it, they will usually contact you directly.¹

What’s being done about it?

UKHSA’s role in an outbreak is to identify cases, trace close contacts, arrange precautionary antibiotics, advise schools and universities, and recommend targeted vaccination where needed.

Here at Wessex Private GP, we understand why this news can be frightening. The overall numbers are reassuring, but staying alert to symptoms still matters.

We are also working with the Kingston Wing in Yeovil to explore whether WPGP may be able to offer MenB vaccination privately. We will keep you posted on this via our website.

Take-home message

Meningitis is rare but serious. If you or a loved one has symptoms you’re concerned about, get help quickly. If this means bypassing a GP and going straight to A&E when you’re really worried, that’s fine.

Helpful resources:

NHS meningitis information
NHS MenB vaccine information
UKHSA meningococcal disease guidance
Meningitis Research Foundation
Meningitis Now

Sources:

1. UKHSA. Cases of invasive meningococcal disease notified in Kent (updated 17 March 2026) 
2. UKHSA. Invasive meningococcal disease in England: annual laboratory-confirmed reports for epidemiological year 2024 to 2025 (13 November 2025)
3. NHS. MenB vaccine for children
4. UKHSA. Meningococcal B (MenB) vaccination programme
5. UKHSA. Meningococcal disease: guidance on public health management (updated 23 December 2025)
6. NHS England. Green Book guidance on MenB vaccination in higher-risk groups

Many people living with weight challenges have heard the same messages for years. Modern research has helped us understand that obesity is far more complex than many of these older beliefs suggested. Obesity is a complex condition influenced by biology, genetics, environment and behaviour.

Effective treatment usually combines lifestyle changes, behavioural support, and, sometimes, medication and/or surgery.

Myth 1: ‘Weight is just about willpower’

For a long time, people were told that losing weight simply required eating less and moving more. While lifestyle choices are important, we now know that body weight is also influenced by genetics, hormones, brain signalling, sleep, stress and the obesogenic environment, in particular the modern food environment. Appetite regulation in the brain and metabolic adaptations can make weight loss and maintenance much harder than they appear on the outside. Recognising obesity as an inflammatory chronic medical condition helps move the conversation away from blame and towards effective support.

Myth 2: ‘If you lose weight quickly, you can always keep it off’

Many people have successfully lost weight in the short term through restrictive diets. However the body often responds to weight loss by increasing hunger hormones and lowering energy expenditure, making regain common. ‘Yo-yo dieting’ is the repeated cycle of losing weight through strict dieting and then regaining it again, often because the body adapts by slowing metabolism and increasing hunger, making long-term weight maintenance difficult. Sustainable weight management usually involves gradual lifestyle change, building supportive habits and protecting muscle mass through adequate protein intake and strength activity (resistance exercise).

Myth 3: ‘All calories are the same’

While energy balance matters, the type of food we eat can influence hunger, satiety (feeling full) and metabolic health. Metabolic health means your body is efficiently managing blood sugar, blood pressure, cholesterol, and energy balance to support overall health. Meals rich in protein, fibre and whole foods tend to keep people fuller for longer, whereas highly processed foods can be easy to overconsume and are likely to trigger reward pathways in the brain. The quality of food therefore plays an important role in appetite regulation and long-term weight management.

Our brains are wired to help us survive by encouraging behaviours that feel rewarding. When we do something enjoyable—such as eating, socialising or being active—the brain releases a chemical called dopamine, which creates a sense of pleasure and satisfaction. This system is often called the brain’s reward pathway.

Over time, the brain learns to link certain situations or cues with that feeling of reward. For example, seeing a favourite snack in the cupboard, smelling food cooking, feeling bored in the evening, or sitting down to watch television may all act as triggers. These triggers can lead to a craving, which then leads to eating, followed by the pleasurable feeling of reward. The brain remembers this pattern and becomes more likely to repeat it.

In today’s food environment, many foods are designed to be very appealing. Highly processed foods often combine sugar, fat, salt and flavourings in ways that strongly stimulate the brain’s reward system. This is one reason why people may feel it is difficult to stop eating these foods once they start—it is not simply about willpower, but about how the brain responds to these powerful signals.

Another helpful concept is that different foods affect the body in different ways once we eat them. For example, protein-rich foods such as eggs, yoghurt, beans, fish or chicken tend to keep us fuller for longer. This is partly because the body has to work a little harder to digest protein compared with carbohydrates or fats. In simple terms, digesting protein uses slightly more energy (calories) than digesting the other macronutrients. This does not mean protein is a magic solution, but it is one reason why meals that include good sources of protein often feel more satisfying and may help reduce snacking later.

The encouraging part is that the brain is adaptable. By changing our environment, building new routines and choosing balanced meals that include protein, fibre and whole foods, we can gradually create new patterns. Over time, the brain begins to associate reward with healthier habits instead. With small, repeated changes, the craving–reward cycle can slowly be ‘rewired’, making healthier choices feel more natural.

Myth 4: ‘Medication for weight is the easy way out’

For some individuals, medications can be a helpful medical tool when lifestyle changes alone have not been enough. Treatments such as Semaglutide (Wegovy) and Tirzepatide (Mounjaro) work by affecting appetite signals, satiety and blood sugar regulation. They have been shown to reduce the risk of major cardiovascular events such as heart attack and stroke in people with obesity and/or type 2 diabetes. They do not replace healthy habits, but can make it easier for people to implement them by reducing cravings and excessive hunger.

Myth 5: ‘Obesity is only about appearance’

In reality, obesity is closely linked with many health conditions, including type 2 diabetes, cardiovascular disease, fatty liver disease and joint problems. Even modest weight reduction—around 5–10% of body weight—can lead to meaningful improvements in blood pressure, blood sugar and overall health. The goal is therefore not cosmetic change but improved wellbeing, mobility and quality of life.

The key message is that obesity is a complex chronic condition influenced by biology, environment and behaviour. Effective treatment usually involves a combination of nutrition, physical activity, behavioural support, and, in some cases, medical therapies. Understanding the science helps to approach weight management with greater compassion, realism and hope.

For more advice from our weight loss expert Dr Ulrike Naumann, get in touch to arrange an appointment at our Weight Loss Clinic. Explore how medical expertise, lifestyle guidance, and – where appropriate – judicious use of medication can support your goals.

Prostate cancer is the most common cancer in men, and early detection can make a life‑changing difference. Widespread prostate cancer screening is not available on the NHS, although NHS GPs can offer the PSA blood test to those who are concerned or have symptoms.

The PSA test is useful when it comes back very high or very low, indicating a high or low risk of cancer respectively, but less useful when the result is in between. In these situations it can sometimes miss aggressive cancers or lead to unnecessary investigations or even treatment.

But there is another way. At Wessex Private GP, we’re pleased to offer the Stockholm3 test – an advanced blood test that provides a clearer, more reliable picture of your prostate cancer risk.

What is the Stockholm3 Test?

Stockholm3 is an innovative blood test for men aged 45–74 and no previous prostate cancer diagnosis.

It works by combining:

  • PSA plus three additional protein markers
  • A panel of genetic markers (SNPs)
  • Clinical factors, including age and family history

Why is Stockholm3 better than PSA alone?

  1. Detects more aggressive cancers – earlier
    Many aggressive prostate cancers do not raise PSA levels significantly, especially at early stages.
  2. Reduces unnecessary biopsies and MRIs
    Stockholm3 can reduce unnecessary biopsies by up to 50%.
  3. Clear, personalised recommendations
    Your report includes your individual risk score and advice on next steps.
  4. Backed by strong scientific evidence
    Validated in studies involving over 90,000 men and used clinically in Sweden & Norway since 2017.

Experts briefing the UK National Institute for Health and Care Excellence (NICE) recognised the value of the Stockholm 3 test stating that:

‘The evidence suggests that Stockholm3 is more effective at predicting risk of prostate cancer than PSA testing alone for people aged 45 to 74.’ 

Who should consider the Stockholm3 Test?

If you’re interested, you can have the test with us even if you don’t have any symptoms. Studies have tested the Stockhom3 on large a number of men without symptoms, and it performs well. However, you must be eligible. You are eligible for the Stockholm3 if you are:

  • A man aged 45–74
  • Without a previous prostate cancer diagnosis

The test involves a simple blood draw at our clinic. Your GP will review your personalised risk score and discuss recommended next steps.

What if my risk is high?

The GP you saw will make a personalised recommendation. We can refer for MRI scanning, advise on regular PSA testing, or we may choose to refer you to a specialist. We can refer either privately on on the NHS, whose services accept our cancer referrals directly if their criteria are met.

How to arrange your Stockholm3 Test at Wessex Private GP

Please book a prostate health review. This 30-minute health check costs £185. At it, your doctor will take a detailed, prostate focused history, perform an examination and offer the Stockholm3 if you’re eligible.

If you’re eligible and interested, we will send your blood to our lab, who will first check your PSA, and then perform the Stockhom3 on the same sample if your PSA is greater than 1.5. However, if your PSA is less than 1.5, then the Stockholm3 is not required as your risk is low. If the Stockhom3 is done, we will charge you an additional £395. Only one blood draw is required for this process, which we perform at your prostate health review.

For more information, you can download the patient information from our partner laboratory here:

Stockholm3 Patient Postcard (March 2025):

Click to open PDF

Stockholm3 Full Brochure (May 2024):

Click to open PDF

WHAT OUR PATIENTS SAY ABOUT US

 

“Just to say a big thank you for the conversation this week and the materials that you emailed through afterwards. Plenty of food for thought (food to help weight management, for once!).”

“Highly delighted with my consultation with Dr Middle. He is very personable and easy to talk to as well as being very thorough and professional. I will have no hesitation in consulting with him again.”

“Thanks for the great service to date, Charlie; nice to feel you are connected to the patent’s journey, accessible and responsive – things that are certainly hard to come by.”

“I saw Dr Middle in July this year regarding B12 to treat symptoms of ME/CFS which the NHS would no longer provide. I met with him in his Poundbury surgery and he was friendly, sympathetic and understanding. Excellent value and service I couldn’t rate highly enough. Many thanks.”

“Great appointment – lively doctor!”

“We have seen Dr Middle for the third time and are so happy we found him. My husband has ongoing serious back problems and is in a wheelchair. Besides the excellent and friendly treatment from Dr Middle (which always has help him massively to reduce the constant pain he is in), the building is very accessible for wheelchairs, which of course is a huge help. So we can recommend Dr Middle on every front!!! Thanks again.”

“I was very pleased with my first consultation with Dr Middle. I shall definitely make use of the Wessex Private GP service again.”

“Dr Middle provided excellent, personalised care to me. He was extremely attentive, empathetic and unhurried throughout the consultation. I really appreciate his work ethic and non-pressured, relaxed yet informed approach. Many thanks.”

“Excellent doctor and very prompt response to all requests. Appointments easy and quick to arrange.”

“I would like to thank Dr Middle for his kindness and understanding and prompt action in getting me seen at the hospital the same day I saw him, I will definitely recommend him to family and friends, and would not hesitate to use him again in the future.”

“Dr Middle could not have been more helpful over the past year while I have had a few medical issues. He has listened without judgement, allowed me space to make my own decisions whilst being clear about the best medical options, and supported me throughout the process in a kind and completely professional manner. I wouldn’t hesitate to recommend him.”

“Wessex Private GP service is a great addition to our local health provision. Dr Middle, as a long established GP here, is well known and highly regarded by other clinicians in the area. I found it very easy to make an appointment, and saw Dr Middle in The Kingston Wing at Yeovil Hospital. It was great to have plenty of time to discuss the problem with Dr Middle who listened carefully and was able to conduct a small procedure there and then. I will certainly use this excellent service again if I need.”

“Great service. Able to make an appointment when it suited me, within a few days of my ringing for an appointment. Unfortunately NHS would take at least three months.”

“I have just seen Dr Charles Middle for a private GP appointment. His empathy, kindness and quick understanding of my problem together with an agreed and entirely appropriate plan to resolve my issues was commendable. He is an excellent, talented and natural GP in whom I have every confidence. Thank you very much indeed.”

“Thanks, Charles, for seeing me today. I appreciated the opportunity to have an extended chat with you about my health which fulfilled my expectations. With some of your suggestions I feel better equipped to, hopefully, age with good health and longevity.”

“Thank you for hastening the process and all your support and getting me on the right track.”

“I really appreciate your kindness and compassion. Thank you!”

“Thank you, Dr Middle… that was seamless and has prevented a lot of stress. Thank you for your kindness.”

“You have created a wonderful practice with old-fashioned values and modern expertise. I am so grateful.”

“What a joy to meet such a lovely, understanding doctor!”

“Dr Middle provided an excellent service. He was kind and compassionate and I couldn’t have asked for a better service. I would highly recommend.”

“Excellent and highly professional. Matt’s support goes way beyond a typical GP, as he is 100% dedicated to helping busy people to prioritise their health. By first creating a baseline snapshot of your health today and listening carefully to your own personal goals, he is then able to build a tailored program focused on diet, exercise and other factors to help keep you on the path towards reaching those goals.”

“My wife conveys thanks to you, as she felt such relief that at last someone was listening, moreover listening with sympathy, understanding and professional competence. Without your diagnosis and actions, I can’t imagine where we would be. Thank you so very much.”

“I have very good feedback from today’s appointment. Thorough and informative. Friendly too. Many thanks.”

“Katie Thomas was terrific, thank you so much!”

“Dr Middle was a very kind and caring. He put me at ease immediately and listened patiently as I tried to explain myself. I would highly recommend Dr Middle.”

“My feedback for your service is that you were thoughtful and listened kindly – an excellent service.”

“Saw Dr Middle today and he was fantastic; very impressed with how thorough he was and how much he genuinely cared about me.”

“Thank you very much for the excellent consultation yesterday. I cannot fault you in any way. For the first time in several years, I experienced a genuine sense of being cared for by a medical professional. Having lost trust in doctors over the past decade, I was initially apprehensive, but my apprehension was quickly dispelled.”

“I just want to say a huge thank you to Dr Phelan for the reassurance and for explaining everything in such detail for me. I came away feeling very positive after the appointment.”

“I was really impressed. The doctor was very helpful, informative, and thorough – excellent service, thank you.”

“Thank you very much for coming back to me so quickly with my results. It really has put my mind at rest. Thank you again for being kind, reassuring and very informative.”

“A first-class experience across the board. The doctor ticks all my boxes!”

“I would absolutely recommend Wessex Private General Practice. It was my first visit and Dr Matthew Phelan was patient, kind and understanding, but above all listened and has already started actioning the process of what has been a very long and complicated medical history. Finally!”

“An outstanding consultation with a high grade professional. Doctor Thomas was punctual, personable and very patient. This was a comprehensive examination done in a friendly and helpful manner, using clear language. The diagnosis and way ahead were clearly set out and I now await the result of some tests. Very many thanks.”

“Very good consultation and speedy appointment.”

“As helpful, professional and empathic as ever. It is such a boon to be able to talk face to face with an experienced GP; it is so facilitating.”

“I am so pleased to have found this practice. Extremely professional, every query is dealt with quickly and efficiently. Good options for in person or telephone appointments with a diligent and courteous follow up. I would thoroughly recommend.”

“The doctor was extremely supportive, both in dealing with the physical problem and understanding the mental and emotional issues that go with it.”

“We see Dr Middle every 12 weeks for our B12 injections. We find the injections extremely beneficial, including a significant energy boost, improved mental clarity, and better mood regulation. These can also promote healthy skin, hair, and nails also
We highly recommend this practice.”

“Thought it was time to write to you to express my thanks and appreciation of the Wessex Private Practice, and the considerable, comprehensive help and kindness shown to me by Doctor Mark Morgan. With his help, I have been able to move forward in resolving my medical issue, after being unable to get the help I needed from the NHS. As such, I will be happy to recommend your services to others.”

“I always leave my appointments with Dr Phelan feeling reassured physically and more confident mentally.”

“I think all of you are excellent. Kind, helpful, and thoughtful.”

“Just a quick email to say thank you to Dr Phelan, who saw my daughter today. She was a little apprehensive due to previous negative experiences with our local practice. She finally felt as if she had been listened to and taken seriously.”

OUR LOCATIONS

The Poundbury Clinic, Middlemarsh Street, Poundbury, Dorchester, DT1 3FD

The Kingston Wing, Yeovil Hospital, Higher Kingston, Yeovil, Somerset, BA21 4AT

Wincanton Community Hospital, Dancing Lane, Wincanton, BA9 9DQ

GET IN TOUCH

Tel: 01935 609453

Email: clinic@wessexprivategp.co.uk

Book online

Heart On Hand by Iconika; Clock by IronSV; Calendar Clock by Econceptive; Check by Kieu Thi Kim Cuong; Unlock User by iconsphere from NounProject.com

Complaints Procedure Safeguarding Children Policy Safeguarding Policy Privacy Policy New Patient Registration Form Patient Feedback
CQC Registration Certificate CQC Registered Manager